{
    "complex": true,
    "leverage": false,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "ucits": true,
    "type": "ETF",
    "complex_factors": [
        "Synthetic replication using swaps",
        "Counterparty risk exposure",
        "Derivative instruments for replication"
    ],
    "classification": "complex",
    "supporting_data": "The ETF uses synthetic replication via a swap agreement with UBS AG as the counterparty, which introduces counterparty risk and complexity beyond physical replication. The KIID explicitly mentions financial derivative instruments (FDIs) and the transfer of index performance via swaps, confirming the synthetic structure. The risk profile (category 6) and extensive counterparty risk disclosures further support the complexity classification. While the ETF does not use leverage or inverse strategies, the reliance on derivatives for replication and the associated risks make it complex under MiFID II.",
    "confidence": 90,
    "counter_argument": "The ETF is UCITS-compliant and tracks a well-known, liquid index (MSCI USA), which might suggest simplicity. However, the synthetic replication and counterparty risk override this, as MiFID II explicitly flags such structures as complex due to the additional risks and the need for investor understanding of derivative mechanics.",
    "risk_level": 6,
    "additional_notes": "The ETF's factsheet confirms the synthetic replication method and the use of collateral (G10 government bonds, supranational bonds, and cash) to mitigate counterparty risk, but the complexity arises from the derivative-based structure itself. The absence of leverage or inverse exposure does not negate the complexity introduced by the swap agreement."
}